Form 483

Tissue Bank International/The National Eye Bank Center Form 483, 2012-06-20

FDA issued a Form 483 to Tissue Bank International/The National Eye Bank Center on 2012-06-20 with 5 public-safe observations.

483· Form 483 issued5 observations

Tissue Bank International/The National Eye Bank Center · Memphis, United States · Issued June 20, 2012

Overview

  • 5 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Jun 2012
21 CFR 1271.180(a)

Procedures to meet core CTGP

Cited by Danielle M Maddox

20 Jun 2012
21 CFR 1271.195(c)

Monitoring-microorganisms where appropriate

Cited by Danielle M Maddox

20 Jun 2012
21 CFR 1271.230(b)

Reduced risk representation

Cited by Danielle M Maddox

20 Jun 2012
21 CFR 1271.260(e)

Storage temperatures recorded, maintained

Cited by Danielle M Maddox

20 Jun 2012
21 CFR 1271.260(e)

Temperature limits

Cited by Danielle M Maddox

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.260(e)Cited across public-safe Form 483 observations2x
21 CFR 1271.180(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.195(c)Cited across public-safe Form 483 observations1x
21 CFR 1271.230(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere